Beta-amyloid-induced synthesis of the ganglioside GD3 is a requisite for cell cycle reactivation and apoptosis in neurons

J Neurosci. 2002 May 15;22(10):3963-8. doi: 10.1523/JNEUROSCI.22-10-03963.2002.

Abstract

We have shown that cortical neurons challenged with toxic concentrations of beta-amyloid peptide (betaAP) enter the S phase of the cell cycle before apoptotic death. Searching for a signaling molecule that lies at the border between cell proliferation and apoptotic death, we focused on the disialoganglioside GD3. Exposure of rat cultured cortical neurons to 25 microm betaAP(25-35) induced a substantial increase in the intracellular levels of GD3 after 4 hr, a time that precedes neuronal entry into S phase. GD3 levels decreased but still remained higher than in the control cultures after 16 hr of exposure to betaAP(25-35). Confocal microscopy analysis showed that the GD3 synthesized in response to betaAP colocalized with nuclear chromatin. The increase in GD3 was associated with a reduction of sphingomyelin (the main source of the ganglioside precursor ceramide) and with the induction of alpha-2,8-sialyltransferase (GD3 synthase), the enzyme that forms GD3 from the monosialoganglioside GM3. A causal relationship between GD3, cell-cycle activation, and apoptosis was demonstrated by treating the cultures with antisense oligonucleotides directed against GD3 synthase. This treatment, which reduced betaAP(25-35)-stimulated GD3 formation by approximately 50%, abolished the neuronal entry into the S phase and was protective against betaAP(25-35)-induced apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / pharmacology*
  • Animals
  • Apoptosis / drug effects
  • Apoptosis / physiology*
  • Cell Count
  • Cell Cycle / drug effects
  • Cell Cycle / physiology
  • Cells, Cultured
  • Chromatin / metabolism
  • Excitatory Amino Acid Antagonists / pharmacology
  • Gangliosides / biosynthesis*
  • Microscopy, Fluorescence
  • Neurons / cytology
  • Neurons / drug effects*
  • Neurons / metabolism*
  • Oligonucleotides, Antisense / pharmacology
  • Peptide Fragments / pharmacology*
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / biosynthesis
  • Rats
  • Reverse Transcriptase Polymerase Chain Reaction
  • S Phase / drug effects
  • S Phase / physiology
  • Sialyltransferases / antagonists & inhibitors
  • Sialyltransferases / genetics
  • Sialyltransferases / metabolism
  • Sphingomyelins / metabolism
  • beta-D-Galactoside alpha 2-6-Sialyltransferase

Substances

  • Amyloid beta-Peptides
  • Chromatin
  • Excitatory Amino Acid Antagonists
  • Gangliosides
  • Oligonucleotides, Antisense
  • Peptide Fragments
  • RNA, Messenger
  • Sphingomyelins
  • amyloid beta-protein (25-35)
  • ganglioside, GD3
  • Sialyltransferases
  • beta-D-Galactoside alpha 2-6-Sialyltransferase